Sarcoma trials in New Zealand

In New Zealand 6 Also abroad 605

6 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Where
Auckland
Age
18 years and over
People
348 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06345729 · EU 2023-507776-42-00
Phase 1Taking people
A First-in-Human Study Investigating BG-85738 Alone or in Combination With Other Antitumor Agents in Patients With Advanced or Metastatic Solid Tumors With Rat Sarcoma Virus (RAS) Mutations
Where
Auckland
Age
18 years and over
People
100 worldwide
Run by
BeOne Medicines
See details and how to joinNCT07746141 · EU 2026-526560-20-00
Phase 1Taking people
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
Where
Auckland, Christchurch
Age
18 years and over
People
405 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06884618 · EU 2024-519622-20-00
Phase 3Taking people
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Where
Christchurch, Grafton
Age
Up to 50 years
People
62 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT05235165
Phase 3Taking people
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Where
Christchurch, Grafton
Age
Up to 21 years
People
205 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT05304585
Phase 1/2Taking people
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Where
Auckland, Christchurch
People
1,672 worldwide
Run by
University of Birmingham
See details and how to joinNCT04625907 · EU 2024-510579-40-00